Scopus BioPharma (SCPS) Form 3 Scopus BioPharma / Paul Hopper ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Hopper Paul

(Last) (First) (Middle)

101/50 MCLACHLAN AVENUE

(Street)

RUSHCUTTERS BAY C3 2011

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/15/2020

3. Issuer Name and Ticker or Trading Symbol
Scopus BioPharma Inc. [ SCPS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	$700,000(1)	I	By Moreglade Pty. Limited
Common Stock	$6,333(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
W Warrant	10/01/2021	09/30/2026	B Unit	$503,636(1)	(3)	I	By Moreglade Pty. Limited
W Warrant	10/01/2021	09/30/2026	B Unit	$4,557(4)	(3)	D

Explanation of Responses:

1. Mr. Hopper is a director of Moreglade Pty. Limited and therefore is deemed to have shared voting and dispositive power over the shares of Common Stock and W Warrants held by this entity. Mr. Hopper disclaims beneficial ownership of the shares of Common Stock and W Warrants held by this entity, as he has no pecuniary interest therein.

2. Excludes 6,333 shares owned by Mr. Hopper's spouse and an aggregate of 50,668 shares owned by Mr. Hopper's adult children, as to which shares he disclaims beneficial ownership.

3. Each W Warrant is exercisable for one B Unit. Starting on April 1, 2022, each B Unit can be separated into one share of common stock and one Z Warrant. Each Z Warrant is exercisable for one share of common stock with an exercise price of $5.00 per share. The Z Warrant will become exercisable on July 1, 2022 and will expire on June 30, 2027.

4. Excludes 4,557 W Warrants owned by Mr. Hopper's spouse and an aggregate of 36,452 W Warrants owned by Mr. Hopper's adult children, as to which warrants he disclaims beneficial ownership.

	/s/ Paul Hopper	11/17/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.